Technical Addendum
IEc 60601
Immunity test
test Level
Conducted RF
3 Vrms
IEC 61000-4-6
150kHz to 80MHz
Radiated RF
3 V/m
IEC 61000-4-3
80MHz to 2,5GHz
NotE: At 80 MHz and 800 MHz, the higher frequency range applies.
NotE: These guidelines may not apply in all situations. Electromagnetic propagation is affected by absorption
and reflection from structures, objects and people.
a
Field strengths from fixed transmitters, such as base stations for radio (cellular/cordless) telephones and land mobile radios, amateur radio, AM and
FM radio broadcast and TV broadcast cannot be predicted theoretically with accuracy. To assess the electromagnetic environment due to fixed RF
transmitters, an electromagnetic sire survey should be considered. If the measured field strength in the location in which the InSpectra StO
Oxygenation Monitor is used exeeds the applicable RF compliance level above, the InSpectra StO
verify normal operation. If abnormal performance is observed, additional measures may be necessary, such as reorienting or relocating the InSpectra
StO
Tissue Oxygenation Monitor.
2
b
Over the frequency range 150 kHz to 80 MHz, field strengths should be less than 3 V/m.
36
Technical Addendum
compliance
Electromagnetic
Level
Environment – Guidance
3 Vrms
Portable and mobile RF communications
equipment should be used no closer to
any part of the InSpectra StO
Oxygenation Monitor, including cables,
than the recommended separation distance
3 V/m
calculated from the equation applicable to
the frequency of the transmitter.
Recommended separation distance
d = 1,2√P
d = 1,2√P 80MHz to 800MHz
d = 1,2√P 800MHz to 2,5GHz
Where P is the maximum output power
rating of the transmitter in watts (W)
according to the transmitter manufacturer
and d is the recommended separation
distance in meters (m).
Field strengths from fixed RF transmitters,
as determined by an electromagnetic
site survey,
compliance level in each frequency range.
Interference may occur in the vicinity
of equipment marked with the following
symbol:
should be less than the
a
Tissue Oxygenation Monitor should be observed to
2
table 202 (continued)
Tissue
2
b
Tissue
2